EdgeTestMarket TodayOptions TodayIPO
Start free

BAFNAPHBafna Pharmaceuticals Limited

Rs 434.1▼ -2.00%
Market closedEquity EOD 26 Oct
Compare
52-week rangeThe lowest and highest prices the stock traded at over the last year, from each day's intraday low and high. The marker is today's close: 0% means it sits at the year's low, 100% at the high. It describes where the price is, not where it is going.88.1% up the range
Rs 95Rs 480
BAFNAPH price
Daily candles, adjusted for splits and bonus issues so a corporate action does not show as a crash. Pick a window from one month to the full history, add indicators, or open it full screen.
EOD 26 Oct
IndicatorsVolume

Loading BAFNAPH price...

At a glance
Each figure is shown against the company's sector (the track: the dot is this company, the tick is the sector middle) and, where we hold the yearly filings, against its own recent years (the small trend line).
Market capWhat the whole company is worth on the stock market today: share price times the number of shares. It measures size, not quality.
Rs 1,027 cr
No sector comparison yet
P/EPrice to earnings: how many rupees investors pay for each rupee of profit the company made over the last twelve months. Compare it with similar companies rather than reading it alone.
131.9x
No sector comparison yet
Price to bookPrice to book: the share price divided by the shareholders' money per share in the latest balance sheet. Around 1 means the market values the company close to its book value.
10.7x
No sector comparison yet
ROEReturn on equity: the year's profit as a percentage of the shareholders' money in the business. It shows how much the company earns on what its owners have put in.
8.1%
No sector comparison yet
FY23 15.4%FY26 11.5%
ROCEReturn on capital employed: operating profit as a percentage of all the long-term money in the business, owners' and lenders'. It shows how well the company uses its capital, whatever the mix of debt.
12.4%
No sector comparison yet
FY23 16.4%FY26 12.4%
Debt to equityBorrowings divided by shareholders' money. 0 means no borrowings; 1 means it owes as much as its owners have put in. Not shown for banks and lenders, whose borrowing is their business.
0.39
No sector comparison yet
FY23 0.31FY26 0.39
Dividend yieldDividends paid over the last year as a percentage of the company's market value: roughly what Rs 100 of shares paid out in cash.
0.0%
No sector comparison yet
Sales growthHow much the latest quarter's sales grew against the same quarter a year earlier.
-23.2%
No sector comparison yet
FY23 35.5%FY26 3.2%
What the numbers say
Short lines written by fixed rules from the company's own filings and shareholding. A line appears only when the figures cross the rule (for example sales growing three years running), and each names the numbers behind it. Nothing here is a view on whether to own the share.

Latest quarterIn the quarter to June 2026 (results filed 11 Aug 2026), sales fell 23.2% from a year earlier to Rs 26.6 cr and profit fell 97.8% to Rs 0.1 cr.

Going well
  • Cash from operations was at least the reported profit in each of FY24, FY25, FY26.

Each line is written by a fixed rule from the company's own filings and share price, and names the figures it uses. It describes what happened; it is not advice about the share.

How the share moved on results
For each quarterly result we hold: the change from the share's close on the last trading day before the filing to its close on the first trading day after it. Results can land during market hours or after the close, and this window covers both. It shows what happened, not what will happen next time.

Over the last 20 results, the share rose on 10 and fell on 10, and moved by 3% or more on 12.

Q1 FY23Q1 FY24Q1 FY25Q1 FY26Q1 FY27

Q1 FY27: results filed 11 Aug 2026. The share went from its close on 10 Aug 2026 to its close on 12 Aug 2026 -3.94%.

Where every Rs 100 of sales goes
From the company's own yearly results. Each year is scaled to that year's sales, so you compare shares, not size: how much went on running costs, depreciation, interest and tax, and how much was left as profit.
5 financial years
Sales, last 12 months
Rs 143 Cr
Profit, last 12 months
Rs 8 Cr
Earnings per share
Rs 3.3
Profit growth (qtr, YoY)
-97.78%

Of every Rs 100 of sales in FY26, Rs 89 went on running costs, Rs 4.1 on depreciation, Rs 2.5 on interest; Rs 7.4 was left as profit.

FY22
86
FY23
87
9.8
FY24
93
FY25
92
FY26
89
7.4
Sales (Rs 100)Other incomeRunning costsDepreciationInterestTaxProfitOther items

Thin bar: money in (sales plus other income). Thick bar: where it went. Each year is scaled to its own sales, so the bars compare shares, not size.

How fast it has grown
Compound growth per year in sales, profit and earnings per share between financial years, from the company's own results. A span appears only if our filings cover both ends of it.
Sales
3 yrs
+9.3%/yr
Latest qtr
-23.2%
Profit
3 yrs
-0.6%/yr
Latest qtr
-97.8%

Per year, compounded, between financial years FY26 and the year named; only spans our filings cover. The faint bar is the latest quarter against the same quarter a year earlier. Earnings per share is not shown: filed figures are not adjusted for bonus issues and splits, so its growth would mislead.

Health check, year by year
Margins, returns, debt and interest cover for each financial year. Each row is coloured against this company's own usual level, so you see what is improving and what is slipping.
MeasureFY22FY23FY24FY25FY26
Sales growthSales against the previous financial year.-35.5%32.3%-4.3%3.2%
Operating marginProfit from operations, before depreciation, interest and tax, per Rs 100 of sales.13.5%13.3%7.3%7.7%10.6%
Net marginProfit after everything, per Rs 100 of sales.6.1%9.8%4.8%2.9%7.4%
ROEProfit as a percentage of shareholders' money (from the March balance sheet).-15.4%9.1%4.9%11.5%
ROCEOperating profit as a percentage of all long-term capital, owners' and lenders'.-16.4%10.3%6.8%12.4%
Debt to equityBorrowings divided by shareholders' money. Lower is safer.-0.31x0.30x0.33x0.39x
Interest coverHow many times operating profit covers the interest bill. Higher is safer.7.5x6.8x4.2x2.6x4.0x

Each row is coloured against this company's own usual level, not against other companies: green is better than its middle year, red worse, plain is close to it. ROE, ROCE and debt rows start once the filings carry a full balance sheet (FY22 at the earliest).

What it owns, and how that is paid for
Straight from the March balance sheet in the company's annual filing. Both bars are the whole balance sheet: what the company owns, and where the money for it came from.
as at 2026-03-31

At FY26 it owned Rs 176 Cr of assets. Its owners funded 55% of that and borrowings 21%.

What it owns
48%
16%
25%
Plant, property and projects85 Cr
Investments0 Cr
Inventory29 Cr
Owed by customers44 Cr
Cash and bank2 Cr
Everything else16 Cr
How that is paid for
55%
21%
18%
Shareholders96 Cr
Borrowings37 Cr
Owed to suppliers31 Cr
Other liabilities11 Cr
Cash and equivalents
Rs 2 Cr
Net debt
Rs 35 Cr
Current ratio
1.57x
short-term assets per rupee due soon
Book value / share
Rs 41
Return on assets
4.4%
EV / EBITDA
51.3x

From the March balance sheet in the company's annual filing (2026-03-31). Each bar is the full balance sheet; "everything else" is what the filed total leaves after the named lines.

Where the cash went
Profit is an accounting figure; cash flow is what actually moved. Cash from running the business, plus or minus what was spent on or received from investments, plus or minus what came from or went to lenders and shareholders, equals the change in cash.

In FY26 the business itself brought in Rs 15 Cr, spent Rs 25 Cr on plant and equipment, and cash fell by Rs 1 Cr over the year.

From running the business
+15 Cr
Spent on or received from investing
-22 Cr
From or to lenders and shareholders
+6 Cr
Net change in cash
-1 Cr
Cash from operations for every Rs 100 of profit
Rs 44
FY23
Rs 129
FY24
Rs 533
FY25
Rs 138
FY26

Rs 100 or more means every rupee of reported profit arrived as cash.

Full financial year to 2026-03-31, from the company's cash flow statement.

The business
Sales and net profit from the company's own filings, by financial year or by quarter. Hover any bar for that period's complete figures including operating margin and the change against the comparable earlier period. The single TTM figure above is the sum of the last four quarters.
5 years · 20 quarters
Full financial years - the long arc of the business.
Sales growth
+9.3%
a year, 3 years
Profit growth
-0.6%
a year, 3 years
Operating margin
10.6%
latest year
Sales by financial yearRs 151 Cr
Net profit by financial yearRs 11 Cr
FY225 full years · hover a yearFY26

Operating margin has gone from 13.5% to 10.6% over these years - the share of every rupee of sales kept after running costs, before interest and tax. Full financial years only, so a part-year is never shown as a whole one. Hover any year for its complete figures.

Large institutional deals
Bulk and block deals reported by the exchange, where a single large trade is disclosed along with the counterparty's name. Only deals above the exchange's disclosure threshold appear here.
last 2
DatePartySideQtyPriceValue
2026-08-06M7 GLOBAL FUND PCC-AERIONSELL6,66,000284.55Rs 18.95 Cr
2026-08-06CULLINAN OPPRTS FUND VCC-CULLINAN OPPORTUNITIES INCORPORATED VCC SUB FUND 1BUY6,66,000284.55Rs 18.95 Cr
Technical snapshot
Momentum, trend and delivery-based conviction from the actual price and volume history.
EOD 26 Oct
RSI (14) - momentum
66.6Neutral
0 oversold3070overbought 100
vs 50-DMA
+27.34%
vs 200-DMA
+115.99%
1-month
+29.00%
3-month
+82.28%
1-year
+195.63%
Realized vol (30d)
24%
Insider trading disclosures
Promoter, director and other insider trades in the company's own shares, as disclosed to the exchange under SEBI's insider-trading regulations - usually within a few days of the transaction.
last 18 months

Insider trading data unavailable.

Recent announcements
The company's own filings to the exchange - results, board meetings, investor calls - with a link to the source document.
last 6 months

Announcements unavailable.

Want to test a strategy on BAFNAPH?

Backtest an equity strategy on real market data, free - no card needed.

Start free

Equity price, fundamentals and realized volatility are end-of-day / quarterly from real market data. The option chain (PCR, max pain, expected move, IV, OI) is live from the exchange during market hours; outside them it shows the last session's close. Shareholding, insider trades and announcements are the company's own exchange filings. Analysis only, not investment advice.